Randomized controlled phase III trial of adjuvant chemo-immunotherapy with activated killer T cells and dendritic cells in patients with resected primary lung cancer

RT @Oncologia_: Inmunoquimioterapia adyuvante en #CáncerdePulmón células no pequeñas eleva sobrevida a 2 y 5 años vs quimioterapia. https:…

Inmunoquimioterapia adyuvante en #CáncerdePulmón células no pequeñas eleva sobrevida a 2 y 5 años vs quimioterapia. https://t.co/XJYbZn56kf

Controlled trial ..significant prolongation of survival in lung cancer patients with dendritic cells and Nk cells http://t.co/gcnjKle34b

Phase 3 clinical trial showing superior survival post surgery in lung cancer patients receiving dendritic cells http://t.co/gcnjKle34b

Randomized controlled phase III trial of adjuvant chemo-immunotherapy with activated killer T... https://t.co/Ggpa56PYce

Adap: Randomized controlled phase III trial of adjuvant chemo-immunotherapy with activated killer T cells and… http://t.co/RdQ9tK0wC6

Randomized controlled phase III trial of adjuvant chemo-immunotherapy with activated killer T cells and dendritic… http://t.co/N58zgDOoSK